The Disease Site Groups are at the heart of the clinical focus of the RCN, bringing world-class best practices to the McGill-affiliated hospitals, while improving outcomes in cancer survival, quality of life, mortality and patient satisfaction.
These cross-institutional working groups will harmonize care across the McGill-affiliated hospitals by uniting physicians working on specific types of cancer.
Mandate of the Disease Site Groups
Harmonize and improve the quality of care for patients and their families across the McGill-affiliated hospitals.
- Develop a network culture
- Select and track quality indicators
- Lead quality improvement initiatives
- Make emerging treatments and clinical trials available to all patients across the network